dextrothyroxine has been researched along with sorafenib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Le, W; Li, M; Lu, H; Yuan, Y; Zhang, T; Zhou, L; Zuo, H | 1 |
1 other study(ies) available for dextrothyroxine and sorafenib
| Article | Year |
|---|---|
Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Ivermectin; Liver Neoplasms; Mice; Sorafenib | 2022 |